GoKawiilCollaboration in nature has often been overlooked in favour of competition, argues science journalist Rowan Hooper. Plus, what’s really happening with trust in science.
You have full access to this article via your institution.
Hello Nature readers, would you like to get this Briefing in your inbox free every day? Sign up here.
News
The Natural Science Foundation of China (NSFC), the country’s main funder of fundamental research, intends to increase its number of prestigious grants for early-career scientists by 50% — welcome news for early-career scientists, who face intense competition. “In many Chinese universities, early-career academics must win a grant under the NSFC’s Young Scientists Fund to find a job, get a promotion or secure tenure,” says bioinformatician Tong Xinzhao.
Nature | 5 min read
Researchers have launched the first clinical trial to test treatments for the Bundibugyo species of Ebola circulating in the Democratic Republic of the Congo (DRC). The trial will initially test two drugs — an antibody cocktail called MPB-134 and the injectable antiviral drug remdesivir — with the potential to add a third later on. A second trial to test another antiviral called obeldesivir — an oral counterpart to remdesivir — might also kick off in the next few weeks as researchers race to contain what is already one of the worst-ever Ebola outbreaks.
Science | 5 min read
Features & opinion
The Universe is a dark place: around 70% of it seems to be dark energy, a mysterious force that seems to drive accelerating expansion; and dark matter, an invisible ‘something’ that holds galaxies together. These two enigmas were thought to have little in common except their names. Now some theorists are asking if they might be linked though a ‘dark dimension’ — one of the six or seven ‘extra’ dimensions posited by string theory. This idea could account for evidence from the Dark Energy Spectroscopic Instrument (DESI) that the strength of dark energy has gone up and down over time.
... continue reading